Genpact extends partnership with Ferring Pharmaceuticals

Genpact (G) announced the extension of its partnership with Ferring Pharmaceuticals, a research-driven biopharmaceutical company that has operating subsidiaries in more than 50 countries and markets its medicines in over 100 countries. The renewed multi-year agreement will continue the transformation of Ferring’s finance, accounting, and procurement operations with advanced technologies, including AI. Under the agreement, Genpact will continue to streamline workflows, optimize resource allocation, and improve the accuracy and speed of financial transactions. In collaboration with technology partners like Xelix and Blackline, Genpact will automate key processes, such as invoice management and procurement workflows, while establishing robust data analytics capabilities for real-time financial insights. These enhancements aim to deliver significant operational savings and enable Ferring to adapt swiftly to evolving customer and patient needs.